![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 7/08 | |
C07K 14/00 | |||
G01N 33/68 | |||
A61K 39/395 | |||
C07K 14/005 |
(11) | Number of the document | 2859011 |
(13) | Kind of document | T |
(96) | European patent application number | 13727202.7 |
Date of filing the European patent application | 2013-06-06 | |
(97) | Date of publication of the European application | 2015-04-15 |
(45) | Date of publication and mention of the grant of the patent | 2019-12-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2013/061751 |
Date | 2013-06-06 |
(87) | Number | WO 2013/182661 |
Date | 2013-12-12 |
(30) | Number | Date | Country code |
201261656256 P | 2012-06-06 | US |
(72) |
S RENSEN, Birger, NO
ÖKVIST, Mats, NO
HOVDEN, Arnt Ove, NO
GR NVOLD, Maja Sommerfelt, NO
|
(73) |
Bionor Immuno AS,
Klostergata 33 P.O. Box 2870, 3702 Skien,
NO
|
(54) | PEPTIDES DERIVED FROM VIRAL PROTEINS FOR USE AS IMMUNOGENS AND DOSAGE REACTANTS |
PEPTIDES DERIVED FROM VIRAL PROTEINS FOR USE AS IMMUNOGENS AND DOSAGE REACTANTS |